Cited by 228Antifungal resistance and susceptibilityCentral Venous Catheters and HemodialysisInfective Endocarditis Diagnosis and Management

Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials

Nucci, Marcio, Anaissie, Elias, Betts, Robert F., Dupont, Bertrand F., Wu, Chunzhang, Buell, Donald N., Kovanda, Laura, Lortholary, Olivier·2010·Clinical Infectious Diseases

Abstract

BACKGROUND: Patients with candidemia frequently have a central venous catheter (CVC) in place, and its early removal is considered the standard of care. METHODS: We performed a subgroup analysis of 2 phase III, multicenter, double-blind, randomized, controlled trials of candidemia to examine the effects of early CVC removal (within 24 or 48 h after treatment initiation) on the outcomes of 842 patients with candidemia. Inclusion criteria were candidemia, age >16 years, CVC at diagnosis, and receipt of 1 dose of the study drug. Six outcomes were evaluated: treatment success, rates of persistent and recurrent candidemia, time to mycological eradication, and survival at 28 and 42 days. Univariate and multivariate analyses were performed, controlling for potential confounders. RESULTS: In univariate analysis, early CVC removal did not improve time to mycological eradication or rates of persistent or recurrent candidemia but was associated with better treatment success and survival. These benefits were lost in multivariate analysis, which failed to show any beneficial effect of early CVC removal on all 6 outcomes and identified Acute Physiology and Chronic Health Evaluation II score, older age, and persistent neutropenia as the most significant variables. Our findings were consistent across all outcomes and time points (removal within 24 or 48 h and survival at 28 and 42 days). The median time to eradication of candidemia was similar between the 2 study groups. CONCLUSIONS: In this cohort of 842 adults with candidemia followed up prospectively, early CVC removal was not associated with any clinical benefit. These findings suggest an evidence-based re-evaluation of current treatment recommendations.

Integrity signals

Registry

Crossref · 10.1086/653935

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The investigators found no clinical difference in microbiologic outcomes or mortality in the patient group that had the CVC removed within 48 hours versus those that had it retained for the first 48 hours.

    “The investigators found no clinical difference in microbiologic outcomes or mortality in the patient group that had the CVC removed within 48 hours versus those that had it retained for the first 48 hours.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nucci, M., Anaissie, E., Betts, R. F., Dupont, B. F., Wu, C., Buell, D. N., Kovanda, L., & Lortholary, O.
Affiliations
  • University of Arkansas for Medical Sciences (US)
  • University of Rochester (US)
  • Hôpital Necker-Enfants Malades (FR)
Venue
Clinical Infectious Diseases
Published
2010-08
Volume
51
Issue
3
Pages
295-303
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2041099687
Cited by
228
References
31
Citations by year
2026: 6 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 5 · 2020: 10 · 2019: 12 · 2018: 14 · 2017: 11 · 2016: 15 · 2015: 17 · 2014: 29 · 2013: 23 · 2012: 32
FWCI
16.59
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
candidemia, central venous catheter removal, early catheter removal, persistent candidemia, treatment success, survival, neutropenia, APACHE II score, antifungal therapy
MeSH terms
Adult, Aged, Aged, 80 and over, Antifungal Agents, Blood, Candidiasis, Double-Blind Method, Female, Humans, Male, Middle Aged, Prospective Studies, Time Factors, Survival Analysis, Fungemia, Treatment Outcome, Catheter-Related Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review